Skip to main content

From Episodic to Chronic: A Discussion on Headache Transformation

  • Chapter
  • First Online:
Chronic Headache
  • 1271 Accesses

Abstract

A chronic daily headache (CDH) disorder is a very different illness than the more common episodic headache. While the episodic headache patient must cope with the uncertainty of when and where the next attack will occur, the CDH patient is frequently faced with relentless pain. This chapter aims to answer several questions:

First, how do we define CDH and what is the burden, to the individual and society, of this disorder?

Three to four percent of the worldwide population suffers from a chronic daily headache disorder encompassing chronic migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Second, what do we know about the mechanism underlying the transformation from episodic headache to CDH? We review evidence suggesting an underlying genetic vulnerability and involvement of glutamate, calcitonin-related peptide, and serotonin pathways. Finally, what risk factors shift an episodic headache to a daily or near-daily headache? The impact of medication overuse, obesity, sleep disturbances, stress, depression, and menstrual-related migraines on headache progression is discussed.

Our hope is that a greater understanding of headache transformation will lead to novel treatment approaches. At the very least, an awareness of modifiable risk factors may empower patients and help prevent an episodic headache from transforming to a chronic daily headache disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34(1):1–7.

    Article  Google Scholar 

  2. Srikiatkhachorn A, Govitrapong P, Limthavon C. Up-regulation of 5HT-2 serotonin receptor: a possible mechanism of transformed migraine. Headache. 1994;34:8–11.

    Article  CAS  PubMed  Google Scholar 

  3. Gallai V, Alberti A, Coppola F, Floridi A, Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia. 2003;23:166–74.

    Article  CAS  PubMed  Google Scholar 

  4. Cernuda-Morollón E, Ramon C, Vega J, Martínez-Camblor P, Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191–6.

    Article  CAS  PubMed  Google Scholar 

  5. Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009;49:412–8.

    Article  PubMed  Google Scholar 

  6. Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME. Frequency of headaches in children is influenced by headache status in the mother. Headache. 2010;50:973–80.

    Article  PubMed  Google Scholar 

  7. Meletiche D, Lofland J, Young W. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41:573–8.

    Article  CAS  PubMed  Google Scholar 

  8. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow M, Tierce J, Reed M, Lipton R. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2009;49:498–508.

    Article  PubMed  Google Scholar 

  9. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.

    Article  PubMed  CAS  Google Scholar 

  10. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483–90.

    Article  PubMed  CAS  Google Scholar 

  11. Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication overuse headache: a randomized controlled open-label trial. Cephalalgia. 2017;333102417737779.

    Google Scholar 

  12. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.

    Article  PubMed  Google Scholar 

  13. Thorland K, Sun-Edelstein C, Druyts E, Kanters S, Ebrahim S, Bhambri R. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17:107.

    Article  CAS  Google Scholar 

  14. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.

    Article  PubMed  CAS  Google Scholar 

  15. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545–50.

    Article  PubMed  Google Scholar 

  16. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.

    Article  PubMed  Google Scholar 

  17. Domínguez C, Vieites-Prado A, Pérez-Mato M, Sobrino T, Rodríguez-Osorio X, López A, Campos F, Martínez F, Castillo J, Leira R. Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia. 2017;333102417731351.

    Google Scholar 

  18. Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, Loewenthal N, Ifergane G. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31(13):1336–42.

    Article  PubMed  CAS  Google Scholar 

  19. Sancisi E, Cevoli S, Vignatelli L, Nicodemo M, et al. Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache. 2010;50(9):1464–72.

    Article  PubMed  Google Scholar 

  20. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904–10.

    Article  PubMed  Google Scholar 

  21. Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–83.

    Article  PubMed  Google Scholar 

  22. Johnson KG, Zimeba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache. 2013;53(2):333–43.

    Article  PubMed  Google Scholar 

  23. Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache. 2006;46(9):1344–63.

    Article  PubMed  Google Scholar 

  24. Penzien DB, Rains JC, Holroyd KA. Psychological assessment of the recurrent headache sufferer. In: Tollinson CD, Kunkel RS, editors. Headache: diagnosis and treatment. Baltimore, MD: Williams and Williams; 1993. p. 39–49.

    Google Scholar 

  25. D’Amico D, Libro G, Prudenzano MP, Peccarisi C, et al. Stress and chronic headache. J Headache Pain. 2000;1:S49–52.

    Article  PubMed Central  Google Scholar 

  26. Paykel ES, Prusoff BA. Scaling of life events. Arch Gen Psychiatry. 1971;25(4):340–7.

    Article  CAS  PubMed  Google Scholar 

  27. Silberstein S, Olesen J. Chronic migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 613–7.

    Google Scholar 

  28. Costa A, Smeraldi C, Tassorellia R, Grecoa G. Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats. Neurosci Lett. 2005;383:22–9.

    Article  CAS  Google Scholar 

  29. Blanchard EB, Appelbaum KA, Radnitz CL, et al. The refractory headache patient—I: chronic, daily, high intensity headache. Behav Res Ther. 1989;27:403–10.

    Article  CAS  PubMed  Google Scholar 

  30. Holroyd KA, Malinoski PE, O’Donnell FJ, et al. Antidepressant medication and cognitive behavioral therapy for CTTH: predictors of treatment response and dose-response relationships. Headache. 2002;42:456–7.

    Google Scholar 

  31. Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. 2006;46:1377–86.

    Article  PubMed  Google Scholar 

  32. Lake AE. Screening and behavioral management: medication overuse headache—the complex case. Headache. 2008;48:26–31.

    Article  PubMed  Google Scholar 

  33. Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalgia. 2005;25(3):165–78.

    Article  CAS  Google Scholar 

  34. Ashina S, Serrano D, Lipton RB Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. Depression and risk of transformation of episodic to chronic migraine. Headache Pain. 2012;13:615–24.

    Article  Google Scholar 

  35. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44:S4–5.

    Article  PubMed  CAS  Google Scholar 

  36. Rivat C, Becker C, Blugeot A, et al. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain. 2010;150:358–68.

    Article  PubMed  Google Scholar 

  37. Boudreau GP, Grosberg BM, McAllister PJ, Sheftell FD, Lipton RB, Buse DC. Open-label, multicenter study of the efficacy and outcome of onabotulinumtoxin-A treatment in patients with chronic migraine and comorbid depressive disorders. J Headache Pain. 2010;11:S50.

    Google Scholar 

  38. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist. 2004;10:221–34.

    Article  PubMed  Google Scholar 

  39. Zhang M, Liu Y, Zhao M, Wenjing T, Xiaolin W, Zhao D, Shengyuan Y. Depression and anxiety behaviour in a rat model of chronic migraine. Headache Pain. 2017;18(1):27.

    Article  CAS  Google Scholar 

  40. Somerville BW. The influence of progesterone and estradiol upon migraine. Headache. 1972;12(3):93–102.

    Article  CAS  PubMed  Google Scholar 

  41. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna Pace .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pace, A., Mueller, B. (2019). From Episodic to Chronic: A Discussion on Headache Transformation. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91491-6_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91490-9

  • Online ISBN: 978-3-319-91491-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics